μ‐opioid receptor agonist facilitates circulating tumor cell formation in bladder cancer via the MOR/AKT/Slug pathway: a comprehensive study including randomized controlled trial

BACKGROUND: μ‐opioid receptor agonists (MORAs) are indispensable for analgesia in bladder cancer (BC) patients, both during surgery and for chronic pain treatment. Whether MORAs affect BC progression and metastasis remains largely unknown. This study focused on the effects of MORAs on the formation...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoqiang, Zhang, Song, Jin, Di, Luo, Jiamei, Shi, Yumiao, Zhang, Yiqi, Wu, Lingling, Song, Yanling, Su, Diansan, Pan, Zhiying, Chen, Haige, Cao, Ming, Yang, Chaoyong, Yu, Weifeng, Tian, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009666/
https://www.ncbi.nlm.nih.gov/pubmed/36739595
http://dx.doi.org/10.1002/cac2.12408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009666/
https://www.ncbi.nlm.nih.gov/pubmed/36739595
http://dx.doi.org/10.1002/cac2.12408

Ejemplares similares